Evidence map›Paper›PMID 41155412›Full record

ReviewInternational journal of molecular sciences2025

Implications of Altered Endosomal-Lysosomal Biogenesis in Melanoma Pathogenesis.

Giang T Lam, Carmela Martini, Alexandra Sorvina, Shane M Hickey, Madison T Hindes, David Waugh, John J O'Leary, Douglas A Brooks, Jessica M Logan

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Giang T LamClinical and Health Sciences, University of South Australia, Adelaide, SA 5000, Australia.ORCID 0000-0002-2416-1779
Carmela MartiniClinical and Health Sciences, University of South Australia, Adelaide, SA 5000, Australia.ORCID 0000-0002-3891-7696
Alexandra SorvinaCentre for Cancer Biology, University of South Australia, Adelaide, SA 5000, Australia.ORCID 0000-0002-5918-3038
Shane M HickeyClinical and Health Sciences, University of South Australia, Adelaide, SA 5000, Australia.ORCID 0000-0002-3063-531X
Madison T HindesClinical and Health Sciences, University of South Australia, Adelaide, SA 5000, Australia.ORCID 0009-0002-8117-5672
David WaughCentre for Cancer Biology, University of South Australia, Adelaide, SA 5000, Australia.
John J O'LearyDepartment of Histopathology, Trinity College Dublin, D02 PN40 Dublin, Ireland.ORCID 0000-0001-7311-9326
Douglas A BrooksClinical and Health Sciences, University of South Australia, Adelaide, SA 5000, Australia.ORCID 0000-0001-9098-3626
Jessica M LoganClinical and Health Sciences, University of South Australia, Adelaide, SA 5000, Australia.ORCID 0000-0003-4046-6908

Funding

Prostate Cancer Foundation of Australia PIRA 1023Rattigan Family Trust N/AUniversity of South Australia N/A
6 · The paper itself

Abstract

Melanoma exhibits inherent heterogeneity and a high metastatic propensity, posing significant challenges for diagnosis, prognosis, and treatment. There are recognized problems with the visual detection of melanoma, such as amelanocytic lesions, which indicate that melanogenesis is downstream of the critical pathogenesis. The endosome-lysosome system regulates trafficking to control melanogenesis, and endosome function/signaling is directly impacted by common melanoma mutations. The endosomal-lysosomal system is also integrally involved in the regulation of fundamental cellular processes that are associated with other key hallmarks of this cancer. This traditional narrative review explores the relationship between altered endosomal-lysosomal biogenesis, aberrant melanogenesis, and oncogenic function in melanoma, including the potential effects on proliferation, invasion, and metastasis. Elucidating the molecular mechanisms underpinning the altered endosomal-lysosomal biology in melanoma is important as this has the potential to define new diagnostic and prognostic biomarkers to improve patient management.

Indexed as

EndosomesLysosomesMelanomaOrganelle BiogenesisAnimalsHumansMelaninsSignal TransductionMelaninsbiomarkersendosomal–lysosomal biogenesismelanomamelanoma pathogenesis

Identifiers

PMID41155412
PMCPMC12564369

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.